SILVER SPRING, Md. – The XSTAT P15, an advanced hemorrhage control device for narrow-entrance wounds, recently received 510(k) clearance as part of joint efforts by Naval Medical Research Command (NMRC) in partnership with a medical device company, RevMedx.
This device uses advanced technology in a smaller version of an existing combat casualty wound care device, the XSTAT P30, designed to treat life-threatening, bleeding wounds in deployed and combat environments.
Warfighters can use the XSTAT P15 applicator to insert a pouch containing miniature sponges into restricted wound sites, such as those caused by gunshots or shrapnel. As the sponges expand, they exert constant pressure onto the wound, minimizing bleeding without the use of...
01.12.2026 | SILVER SPRING, MARYLAND, US |
Story by Aleece Williams
SILVER SPRING, Md. – The XSTAT P15, an advanced hemorrhage control device for narrow-entrance wounds, recently received 510(k) clearance as part of joint efforts by Naval Medical Research Command (NMRC) in partnership with a medical device company, RevMedx.
This device uses advanced technology in a smaller version of an existing combat casualty wound care device, the XSTAT P30, designed to treat life-threatening, bleeding wounds in deployed and combat environments.
Warfighters can use the XSTAT P15 applicator to insert a pouch containing miniature sponges into restricted wound sites, such as those caused by gunshots or shrapnel. As the sponges expand, they exert constant pressure onto the wound, minimizing bleeding without the use of...
01.12.2026 | SILVER SPRING, MARYLAND, US |
Story by Aleece Williams
SILVER SPRING, Md. – The XSTAT P15, an advanced hemorrhage control device for narrow-entrance wounds, recently received 510(k) clearance as part of joint efforts by Naval Medical Research Command (NMRC) in partnership with a medical device company, RevMedx.
This device uses advanced technology in a smaller version of an existing combat casualty wound care device, the XSTAT P30, designed to treat life-threatening, bleeding wounds in deployed and combat environments.
Warfighters can use the XSTAT P15 applicator to insert a pouch containing miniature sponges into restricted wound sites, such as those caused by gunshots or shrapnel. As the sponges expand, they exert constant pressure onto the wound, minimizing bleeding without the use of...
01.12.2026 | SILVER SPRING, MARYLAND, US |
Story by Aleece Williams
Naval Medical Research Command (NMRC) in partnership with medical device company, RevMedx, developed the XSTAT P15 an advanced hemostatic device designed to control hemorrhaging. This device is supplied in two easy to use pieces, the plunger and barrel. The barrel houses a pouch of miniature sponges that will rapidly expand to fill the wound site and control hemorrhaging. This device requires no training to be applied effectively and efficiently in emergent situations. Navy Medicine Research & Development, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. (U.S. Navy photo by Sidney Hinds/Released)
